Floatz logo

Alfuzosin

Prostatitis

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Small moleculePhase 3Dormant
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Prostatitis cohort.

Asset / SponsorPhaseRating
Ningmitai
Xintian Pharmaceutical
Phase 4BBB
Selenium
Clinica Urologica Molinette - Città della Saliute e della Scienza
Phase 4BB
Serenoa repens extract
Clinica Urologica Molinette - Città della Saliute e della Scienza
Phase 4BB
PALMITIC MONOETHANOLAMIDE
Clinica Urologica Molinette - Città della Saliute e della Scienza
Phase 4BB
Tamsulosin
Xintian Pharmaceutical
Phase 4BB

View all 20 →

Same molecule, other indications

Alfuzosin is also rated in:

urinary bladder disorderDormant
CCC
Indicative ·
55 / 100
View asset →
multiple sclerosisDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →